David Berk
Corporate Officer/Principal chez ARCUTIS BIOTHERAPEUTICS, INC.
Profil
David Berk is currently the Vice President-Research & Development Strategy at Arcutis Biotherapeutics, Inc. He previously worked as the Executive Director & Head-Medical Dermatology at Allergan, Inc. from 2012 to 2018.
Prior to that, he was an Assistant Professor at Washington University in St. Louis from 2009 to 2012.
Dr. Berk holds a doctorate degree from Stanford University and an undergraduate degree from Princeton University.
Postes actifs de David Berk
| Sociétés | Poste | Début |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 |
Anciens postes connus de David Berk
| Sociétés | Poste | Fin |
|---|---|---|
| ALLERGAN, INC. | Director/Board Member | 01/12/2018 |
| Washington University in St. Louis | Corporate Officer/Principal | 01/01/2012 |
Formation de David Berk
| Stanford University | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Allergan, Inc.
 Allergan, Inc. Pharmaceuticals: MajorHealth Technology Allergan, Inc. operated as a global healthcare company. It engaged in the development and commercialization of specialty pharmaceutical, medical device ,and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological, and other specialty markets. The company was founded by Gavin S. Herbert Sr. in 1950 and headquartered in Irvine, CA. | Health Technology |
